FCGR, Cetuximab, and Colorectal Cancer Survival-Letter
Clin Cancer Res
.
2016 Oct 1;22(19):4958.
doi: 10.1158/1078-0432.CCR-16-1470.
Authors
Francesca V Negri
1
,
Daniela Boggiani
1
,
Anita Rimanti
1
,
Antonino Musolino
2
Affiliations
1
Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
2
Medical Oncology Unit, University Hospital of Parma, Parma, Italy. antoninomusolino@hotmail.com.
PMID:
27697992
DOI:
10.1158/1078-0432.CCR-16-1470
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Monoclonal, Humanized
Cetuximab*
Colorectal Neoplasms*
Humans
Substances
Antibodies, Monoclonal, Humanized
Cetuximab